Home / Resources / Articles / Metabolic Syndrome Linked to Testosterone Deficiency

Metabolic Syndrome Linked to Testosterone Deficiency

May 24, 2005
1,233 views
 

Among men studied, those with a history of diabetes, hypertension or hyperlipidemia have a higher prevalence of hypogonadism. Hypogonadism, defined by low testosterone levels in men, is a complex syndrome. Of the 2,162 men in the study, prevalence rate of hypogonadism was 50% for those with diabetes, 42% those with hypertension and 40% for those with hyperlipidemia. Common symptoms associated with hypogonadism include sexual dysfunction, fatigue or weakness, or mood changes.

According to the AACE Medical Guidelines for Clinical Practice for the Evaluation and Treatment of Hypgonadism in Adult Male Patients – 2002 Update, the recognition, evaluation, and treatment of hypogonadism in the male patient are often dismissed by the patient and overlooked by the physician. The symptoms and signs of hypogonadism should be identified through appropriate questioning of the patient and a directed physical examination. Testosterone replacement therapy can often enable the patient to function in a more normal manner and decrease the risk of future problems with fertility, mood disturbances, fatigue, impaired virilization, and osteoporosis.

 

According to new research issued May 18, 2005 at the American Association of Clinical Endocrinologists (AACE) Fourteenth Annual Meeting and Clinical Congress.

=============================

WarmFeet Kit can help with painful neuropathy and wound healing.
To Find our more:
https://www.diabetesincontrol.com/modules.php?name=News&file=article&sid=2007

The 10,000 STEP STUDY:
"The Results". A simple answer to a difficult problem.
https://www.diabetesincontrol.com/modules.php?name=News&file=article&sid=2001

================================

Advertisement

Obtain your patients’ A1C results when they’re most useful. in2it(tm) In-Office Analyzer delivers reimbursable, lab-accurate A1C test results when it truly matters-during a patient’s visit. Because its results are unaffected by Hb variants, in2it(tm) is an easy way to gauge the efficacy of your treatment strategies in less than seven minutes. CLIA waived (cleared for Prescription Home Use, and as a result has been CLIA waived). The in2it(tm) is available with flexible acquisition options. It’s your opportunity to keep your office’s A1C testing simple. So get the analyzer that makes both clinical and business sense. Get in2it(tm) For more information: Click Here
https://www.diabetesincontrol.com/in2it/dest.php